cerebral arterial thrombosis
Conditions
Interventions
The taVNS group:Transcutaneous aural vagus nerve stimulation +Basic treatment+rehabilitation treatment
The sham taVNS group:taVNS stimulates the vagus-rich region of the left auricular tail + Basic treatment+rehabilitation treatment
Routine rehabilitation group:Basic treatment+rehabilitation treatment
Sponsors
The Seventh People's Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. 35 <= 75 years old; 2. Stroke (infarction) occurred for the first time, in the recovery period (course of the disease from 2 months to 6 months), basically stable, unconscious disorder, no obvious language disorder; 3. The diagnosis conforms to the key points of cerebrovascular disease diagnosis adopted by the fourth National Academic Conference on Cerebrovascular Disease in 1995; 4. Unilateral subcortical cerebral infarction (basal ganglia, thalamus, internal capsule, etc.) confirmed by head CT or MRI; 5. Brunnstrom grade of the affected hand 0-3; 6. There is no metal implant or pacemaker in the body; 7. No previous history of epilepsy or clear cognition does not affect communication and assessment; 8. Informed consent signed by the patient himself or by his immediate family member.
Exclusion criteria
Exclusion criteria: 1. Cerebrovascular disease has been present for more than 6 months, or the disease is progressing in the acute phase or the vital signs are unstable; Examination confirmed that there are cerebral hemorrhage, brain trauma, brain tumor, cerebellum and brain stem lesions can cause motor dysfunction and other encephalopathy; 2. If the disease really needs other acupuncture (such as head acupuncture, body acupuncture, etc.) treatment; 3. Exclude bone diseases, joint injuries, or fixed contraction affecting limb deformities, etc.; 4. Cognitive dysfunction is so severe that it is impossible to carry out relevant training and assessment of this subject; 5. Patients with serious diseases of the heart, liver, kidney, endocrine system, and hematopoietic system; 6. Pregnant and lactating women; 7. Those who are participating in other clinical trials that affect the evaluation of the results of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WOLF Motor Function Assessment Scale;Fugl-Meyer scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Function Independent Measure, FIM;The SF-36 scale; | — |
Countries
China
Contacts
Public ContactTiantian Liu
The Seventh People's Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed